Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (101-110 of 329) with videos related to

Pageof 33
Sort By:
AIDS (London, England)|July 6, 2010
Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptomsGiovanna Melica, Ana Canestri, Gilles Peytavin, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010Charlotte Charpentier, Sidonie Lambert-Niclot, Benoit Visseaux, et al.
AIDS (London, England)|December 4, 2002
HIV and antiretroviral drug distribution in plasma and fat tissue of HIV-infected patients with lipodystrophyNicolas Dupin, Marc Buffet, Anne-Geneviève Marcelin, et al.
Infectious Diseases Now|November 2, 2022
Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patientsElisa Teyssou, Stéphane Marot, Théophile Cocherie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2018
Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention TrialAnne Derache, Collins C Iwuji, Kathy Baisley, et al.
Journal of Medical Virology|December 24, 2005
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performanceDiane Descamps, Constance Delaugerre, Bernard Masquelier, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2023
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settingsDaniele Armenia, Maria M Santoro, Charlotte Charpentier, et al.
AIDS (London, England)|August 24, 2010
Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretroviralsSlim Fourati, Isabelle Malet, Mawuena Binka, et al.
AIDS (London, England)|December 9, 2010
Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 yearsCathia Soulie, Sidonie Lambert-Niclot, Marc Wirden, et al.
AIDS (London, England)|September 27, 2005
No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patientsJade Ghosn, Marc Wirden, Nadine Ktorza, et al.
Pageof 33

Showing results (101-110 of 329) with videos related to

Sort By:
Pageof 33
AIDS (London, England)|July 6, 2010
Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptomsGiovanna Melica, Ana Canestri, Gilles Peytavin, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010Charlotte Charpentier, Sidonie Lambert-Niclot, Benoit Visseaux, et al.
AIDS (London, England)|December 4, 2002
HIV and antiretroviral drug distribution in plasma and fat tissue of HIV-infected patients with lipodystrophyNicolas Dupin, Marc Buffet, Anne-Geneviève Marcelin, et al.
Infectious Diseases Now|November 2, 2022
Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patientsElisa Teyssou, Stéphane Marot, Théophile Cocherie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2018
Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention TrialAnne Derache, Collins C Iwuji, Kathy Baisley, et al.
Journal of Medical Virology|December 24, 2005
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performanceDiane Descamps, Constance Delaugerre, Bernard Masquelier, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2023
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settingsDaniele Armenia, Maria M Santoro, Charlotte Charpentier, et al.
AIDS (London, England)|August 24, 2010
Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretroviralsSlim Fourati, Isabelle Malet, Mawuena Binka, et al.
AIDS (London, England)|December 9, 2010
Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 yearsCathia Soulie, Sidonie Lambert-Niclot, Marc Wirden, et al.
AIDS (London, England)|September 27, 2005
No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patientsJade Ghosn, Marc Wirden, Nadine Ktorza, et al.
Pageof 33